| Pharmaceutical Information |
| Drug Name |
Papaverine |
| Drug ID |
BADD_D01670 |
| Description |
An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels. |
| Indications and Usage |
For the treatment of impotence and vasospasms. |
| Marketing Status |
Not Available |
| ATC Code |
A03AD01; G04BE02 |
| DrugBank ID |
DB01113
|
| KEGG ID |
D07425
|
| MeSH ID |
D010208
|
| PubChem ID |
4680
|
| TTD Drug ID |
D0NJ3V
|
| NDC Product Code |
Not Available |
| Synonyms |
Papaverine | Pavatym | Pavabid | Cerespan | Papaverine Hydrochloride | Hydrochloride, Papaverine |
|
| Chemical Information |
| Molecular Formula |
C20H21NO4 |
| CAS Registry Number |
58-74-2 |
| SMILES |
COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
